Risedronate Sodium Tablets 17.5mg “Meiji” by Meiji Seika Pharma Co., Ltd. contains sodium risedronate hydrate, provided as 17.5 mg tablets (YJ code: 3999019F2200). This medication is commonly prescribed for osteoporosis, working to suppress bone resorption and increase bone mass.
Risedronate Sodium Tablets 17.5mg “Meiji”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
